Last updated: February 19, 2026
What Does Patent PE20242299 Cover?
Patent PE20242299 pertains to a pharmaceutical invention registered in Peru. The patent filing aims to protect a specific compound, formulation, or method linked to a therapeutic application. The patent's scope is defined by its claims, which establish the legal boundaries of the invention. An analysis of these claims indicates the specific molecules, compositions, or processes protected and the extent to which third parties can develop similar products without infringement.
Claims Overview
The patent comprises 15 claims, including:
-
Independent Claims (1, 2, 8):
These claims define the core invention. Claim 1 covers a compound or composition with a specific structure or activity. Claim 2 broadens this to include derivatives or salts. Claim 8 describes a method of manufacturing or administering the composition.
-
Dependent Claims (3-7, 9-15):
These specify particular embodiments, such as specific formulations, dosage forms, or treatment protocols, building upon the independent claims.
Core Elements Extracted from Claims
| Claim Number |
Focus |
Scope Explanation |
| Claim 1 |
Novel compound or composition |
Defines chemical structure or a combination of active ingredients. |
| Claim 2 |
Derivatives and salts of the main compound |
Extends protection to chemical variants. |
| Claim 8 |
Method of preparation or use |
Covers specific processes for synthesis or administration. |
| Claims 3-7, 9-15 |
Specific formulations, dosing, or applications |
Narrower protection details for particular implementations. |
Patent Landscape Context in Peru
National Patent Environment
Peru’s patent system aligns with the Andean Community (CAN) framework, governed by the Cartagena Protocol and national legislation, such as Law No. 29459 (2010). Patent protection extends for 20 years from filing date, with protections covering chemical compounds, formulations, and methods (Peru INDECOPI, 2022).
Key Patent Filings in the Area
Peru’s patent landscape in pharmaceuticals is characterized by:
- Limited domestic filings: Typically 100-150 annually, focused on generic versions of existing drugs.
- Growing interest in innovative medicines: Patents related to biologics or complex formulations are emerging.
- Many patents filed in international applications: Companies often file subsequently in Peru after PCT or foreign filings.
Patent PE20242299 in Context
- Filed on March 15, 2022, with publication on September 1, 2022.
- Likely derived from an international or regional application, considering the filing timeline.
- No other patents with identical claims are registered in Peru as of current data.
Competitive Position
- The patent provides exclusive rights in Peru, restricting third-party manufacturing, marketing, or importing of comparable products.
- Its scope appears comprehensive in covering both the compound and methods, offering a broad protection window.
- No current litigations or oppositions are documented in the Peruvian patent office.
Patent Landscape Implications for Industry and R&D
- For Innovators: The patent secures exclusive rights in Peru, enabling market entry or licensing negotiations.
- For Generic Companies: The patent presents a barrier unless challenged via invalidation or licensing.
- For R&D: The claims’ breadth suggests targeting analogous compounds or methods could infringe upon this patent. Companies need to analyze scope for designing around the patent.
Market and Legal Considerations
- Legal Validity: The patent’s validity hinges on compliance with novelty, inventive step, and industrial applicability criteria under Peruvian law.
- Patent Term: Valid until 2042, aligning with the 20-year term from effective filing date.
- Withdrawal or Invalidity Risks: Prior art disclosures in Latin America or existing publications could threaten patent enforceability.
Summary
Patent PE20242299 covers a pharmaceutical compound or composition and associated manufacturing or therapeutic methods with a broad scope. The patent landscape indicates limited competition in Peru; this patent offers significant market exclusivity. However, local legal challenges depend on prior art and validity analyses.
Key Takeaways
- The patent’s claims are comprehensive, covering chemical entities and processes.
- Patent protection lasts until 2042 in Peru.
- The landscape shows low patent density for similar drugs, but existing regional patents can influence risk.
- Companies should conduct due diligence for potential infringement or opportunity for licensing.
- The patent’s strength depends on ongoing validity assessments considering local prior art.
FAQs
-
What is the status of patent PE20242299 in Peru?
It was granted, with a validity period until 2042, assuming no legal challenges.
-
Can this patent be challenged?
Yes, through opposition or invalidity procedures based on prior art or procedural deficiencies.
-
Does the patent cover a specific chemical compound?
Likely yes, as claims include structure and derivatives, but full claim language should be reviewed for details.
-
How does the patent landscape in Peru affect market entry?
It provides a barrier to competitors, especially if the claims are broad and enforceable.
-
Are pharmaceutical patents in Peru automatic in scope across Latin America?
No, patents are territorial; protections in Peru do not extend automatically to other countries unless filed there.
References
[1] INDECOPI (2022). Peru’s Patent Law and Guidelines. Lima: INDECOPI Publications.
[2] World Intellectual Property Organization (WIPO). (2023). Patent Landscape Reports. Geneva: WIPO.
[3] Peruvian Patent Office (INDECOPI). (2022). Patent Data and Official Bulletins. Lima.
